# FDA Inspection 962296 - Astellas Ireland Co., Ltd. - February 12, 2016

Source: https://www.keypedia.com/records/fda_inspections/astellas-ireland-co-ltd/6bb6b34e-6a5d-49f1-bc74-c35dda7e76bc
Source feed: FDA_Inspections

> FDA Inspection 962296 for Astellas Ireland Co., Ltd. on February 12, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 962296
- Company Name: Astellas Ireland Co., Ltd.
- Inspection Date: 2016-02-12
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1271041 - 2022-06-17](https://www.keypedia.com/records/fda_inspections/astellas-ireland-co-ltd/31d53ce9-08a4-4356-b61b-5615023b6886)
- [FDA Inspection 1127818 - 2020-01-17](https://www.keypedia.com/records/fda_inspections/astellas-ireland-co-ltd/1e80cd1a-7004-489e-90b0-7f7f8e64a4b0)
- [FDA Inspection 853359 - 2013-09-19](https://www.keypedia.com/records/fda_inspections/astellas-ireland-co-ltd/ef46a86f-f002-4400-839c-3363a590633a)

Company: https://www.keypedia.com/companies/astellas-ireland-co-ltd/9b0c01b3-245c-4559-a759-3aa95d1bc182

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c